Aggregation of human red blood cells (RBC) and platelets and its reversal by a surface-active substance (Pluronic F68).
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D001799:Blood Sedimentation; D002449:Cell Aggregation / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D003080:Cold Temperature; D003911:Dextrans / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004903:Erythrocyte Aggregation / Q000209:etiology; D004912:Erythrocytes / Q000187:drug effects*; D006801:Humans; D008970:Molecular Weight; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013501:Surface-Active Agents / Q000494:pharmacology / Q000627:therapeutic use*
D003911:Dextrans; D013501:Surface-Active Agents; D000244:Adenosine Diphosphate